*2. Major, Online, Drug Information Resources

Objectives:

  1. Understand the concepts:
    • (a) adverse effects, drug interactions, IV compatibility/incompatibility
    • (b) major compendium
  2. Know the unique features of Clinical Pharmacology, LexiComp, LexiDrugs, Martindale’s, AHFS DI, and DailyMed
  3. Be able to access DailyMed, Clinical Pharmacology, LexiComp, LexiDrugs, AHFS Drug Information, and Martindale’s
  4. Be able to find PPIs using Daily Med
  5. Be able to generate custom Adverse Effects, drug interaction, and compatibility reports using Clinical Pharmacology and/or Lexi-­‐Comp

 

Pay attention to the stars ⭐

Much of the content presented from this point forward will be represented on your exam and/or on the drug resources quiz.  If we were meeting in-person, there are things that I would point out as content that would be sure to be represented on the test.  I’m going to use star symbols ⭐ to point out this content in the course book.   Usually, the test will require that you make a decision based on your knowledge of these pieces of content.

Objective 1 a.  Understand the concepts “adverse effects,” “drug interactions,” and “IV compatibility/incompatibility”

You will be using the major drug information resources to look up drugs’ adverse effects, interactions, and known IV compatibility or incompatibility so it’s important that you understand these concepts.

Adverse effects (also called adverse reactions or side effects)

⭐An adverse reaction  takes place after the drug’s administration to a patient.  It is defined as any undesired drug effect.   Adverse reactions are also called adverse effects or side effects.  Adverse effects range from mild reactions like

drowsiness

picture of a little girl yawning
(Pixabay, free for commercial use, https://pixabay.com/photos/yawning-little-girl-yawn-child-1895561/)

 

or  itching

Woman scratching her skin
(NIAID,  CC BY 2.0, https://www.flickr.com/photos/niaid/48140273032)

 

to more severe and dangerous reactions like suicidal behavior

A picture of a man with a gun to his head.
(PickPik, royalty free, https://www.pickpik.com/suicide-despair-no-output-death-man-mature-68779)

 

 

Drug Interactions

⭐Drug interactions, like adverse effects, take place after a drug is administered to a patient.

Pharmacokinetic interactions

⭐In a pharmacokinetic interaction, a food, beverage, or second drug effects the absorption, metabolism or distribution of the first drug.

Example:

An example of a pharmacokinetic interaction is seen when a patient who takes felopdipine for high blood pressure decides to drink some grapefruit juice.    Grapefruit juice inhibits the action of the enzyme (CYP3A4) that degrades felodipine and the patient is exposed to much more of the active drug than s/he normally would be.  This could result in unexpectedly low blood pressure, fainting episodes, and worse.

The effect of grapefruit juice on the amount of active drug present at different points during felodipine absorption and distribution is shown in the table below.

When patient is not drinking grapefruit juce When patient has drunk grapefruit juice
mouth 100% of the active drug contained in the tablet is still present 100% of the active drug contained in the tablet is still present
after passing through gut lining (which contains CYP3A4) 30% of active drug still present 90% still present
blood carries drug to liver 30% 90%
After passing through the liver (which contains CYP3A4) 15% of drug still present 45% still present
blood  from the liver returns to the heart and is pumped  to the whole body. 15% 45%

The information above is shown in pictorial form in  figure 1 of https://unmc.primo.exlibrisgroup.com/view/action/uresolver.do?operation=resolveService&package_service_id=1279986780006389&institutionId=6389&customerId=6385&VE=true

Pharmacodynamic Interaction

⭐A pharmacodynamic interaction occurs when two drugs have additive or antagonistic effects.

Example:

A stimulant and an antihistamine (with a side effect of drowsiness) will have antagonistic effects.  Thus, their co-ingestion will produce a pharmacodynamic interaction.

 

IV Incompatibility

⭐IV incompatibility, unlike  adverse effects or a drug interaction, occurs before drug administration to a patient.  It is the result of two drugs reacting with each other or changing the nature of the solution when  mixed.

⭐Signs of incompatibility are:

  • a change in visible or electronically-­determined (even if not visible) particulates, haziness or turbidity, frank precipitation, color, or gas evolution after drug mixture.
  • a loss of intact drug >10% within 24 hours when mixture constituents are assayed.

 

Three types of IV incompatibility

Tests are performed to see if drug mixtures are compatible or incompatible in three different types of mixing situations.   The concentrations of the drugs vary in these three situations.

1. admixture 

An example of an admixture would be two drugs and a diluent  mixed in an IV bag.

In the picture below, preparations are being made to add a drug to the IV bag.

Adding a drug to an IV bag
(Tech. Sgt. Christopher Hubenthal, https://www.afcent.af.mil/Units/386th-Air-Expeditionary-Wing/Photos/igphoto/2002081417/)

 

One example of an admixture incompatibility is loss of 50% of one drug’s concentration when a mixture of two drugs sits in an IV bag overnight.

 

2. y-site

The diagram below shows an IV line with a y-site.

graphic of an antibiotic being delivered IV from a hanging bag while the y-site is being used to deliver an anti-emetic from a syringe.

 

Y-cite mixtures usually involve one drug that is being delivered slowly through IV  tubing (often from a hanging IV bag) mixing in the tubing with a second drug when the second drug is administered via a syringe or second IV bag attached to the tubing’s y-site.

One example of such an interaction would be formation of a precipitate  in the tubing when the two drugs come in contact.

 

3. Syringe

A picture of a syringe, vial, and alcohol pad
(toledo alves, https://www.wallpaperflare.com/glass-syringe-disposable-syringe-needle-ampoule-fiole-swab-wallpaper-zragq)

A syringe mixture involves two drugs that are drawn into a syringe for simultaneous delivery

An example of syringe incompatibility:   Two drugs are drawn into a syringe, meet, and the previously clear solutions become milky white.

 

Objective 1b.  Understand the concept “major compendium”

  • Compendium =  A collection of concise but detailed information about a particular subject. ·
  • A drug monograph is a concise summary of the important information about a drug’s properties and therapeutic use
  • Therefore, any collection of drug monographs is a drug information compendium

 

Objective 2.  Know the unique features of Clinical Pharmacology, LexiComp, LexiDrugs, Martindale’s, AHFS DI, and DailyMed

Two of the drug information compendia available at UNMC, Clinical Pharmacology and DailyMed, are available through their own separate interfaces.    a UNMC also licenses Lexi-Comp and its native monograph compendium Lexi-Drugs.  We pay an extra fee to LexiComp to obtain two additional drug compendia in the LexiComp interface, AHFS Drug Information (AHFS DI) and Martindale’s: The Complete Drug Reference.

A diagram shows that Clinical Pharmacology and DailyMed stand-alone while the other three major compendia LexiDrugs, AHFS DI, and Martindale's are all provided through the LexiComp interface.

The table below provides a summary of the the distinctive characteristics (in red) of these major compendia.    Below the table, you will find a more detailed discussion of the distinctive characteristics of these resources and mnemonic devices to help you begin memorizing the distinctives of these compendia.

Table showing the distinctives of the major compendia.

 

I. Resources Published by the Manufacturer under FDA Control

DailyMed

DailyMed is a U.S. government-controlled database.  It gives the public an easy way to obtain the FDA-approved package inserts

  • The package inserts are authored and published by the drugs’ manufacturers (DailyMed has no responsibility for their content.).   
  • Package inserts are frequently called physician’s or pharmacist’s prescribing information, PPIs, FDA-approved monographs, or package labels.
  • Package inserts are approved by the FDA.  They can only provide information on FDA-approved drug uses.  ⭐
  • No uses that have not been approved by the FDA (off-label uses) will be discussed.  This does not mean that off-label uses are illegal.   Much of the totally legal drug use in the U.S. is off-label.
  • The FDA must approve any changes or updates in a package insert.  FDA approval of a new label/package insert takes time.
  • For the reasons listed above, DailyMed, and package inserts in general, are rarely the best resource for answering drug information questions.

 

When is DailyMed the best resource?

DailyMed may be the best resource when you need information that is manufacturer-specific.

    • Each manufacturer/repackager must submit its own package label/insert to the FDA for approval.
    • Different manufacturers  may use different inactive ingredients (excipients) when producing the tablets, capsules, etc. that they distribute.⭐
    • Patients are occasionally allergic to ingredients used as excipients, ingredients like lactose or dyes.
    • DailyMed can be used to find manufacturers that make a needed drug without ingredients that are a problem for a particular patient.  To find the inactive ingredients in a drug preparation:
      • Go to DailyMed
      • Search DailyMed for the drug’s generic or brand name.
      • Find one of the results that corresponds to the form of the drug that is of interest (e.g. intravenous, tablet, nasal spray, etc.) and click on the link to the PPI
      • “Expand all sections” and use Ctl-f(windows) or Command-f(mac) to find the word – inactive.
      • Keep looking for all instances of inactive.  Some package inserts include information about multiple forms of a drug (tablet, capsule, solution for injection, etc.) so be sure you’ve seen the inactive ingredients for the drug form/preparation of interest to you.

DailyMed may be helpful when you need a chemical structure.  Many package inserts include chemical structures.

 

II.  Resources NOT Published by the Manufacturer and NOT under FDA Control

The resources discussed below can cover off-­label  (off-PPI, FDA-­‐unapproved)  therapeutic uses.  Authors/Editors can change content quickly, without FDA approval.

If we were meeting in-person, I would ask the class to repeat the mnemonic devices below out-loud.   I’d suggest you  try saying these out loud and also write them down.  It’s easier to remember pieces of information if you deal with them in a variety of different ways.   The distinctive characteristics of these resources will be covered on the quiz and on the exam.  This reflects the importance of these resources in clinical pharmacy practice.

 

Clinical Pharmacology

  • Includes drug monographs, a variety of custom report tools and more
  • Unique features are:
    • Custom, consumer-level interaction reports. (both LexiComp and Clinical Pharmacology provide professional-level drug interaction reports).⭐
    • Custom, adverse reaction reports.⭐

An image to help the student remember the mnemonic device. "CLI" in "Clinical" = "consumer level interaction". "AR" in "Pharmacology" stands for "adverse reactions."

 

LexiComp

  • Includes drug monographs, a variety of custom report tools and more
  • Unique feature – access to monographs from a variety of sources ⭐

 

A picture highlights the pneumonic device for Lexi-Comp. The "Comp" in "LexiComp" stands for "Compare monographs from different sources."

 

LexiDrugs

  • LexiDrugs is one of the sets of drug monographs that comes with LexiComp without having to pay an additional fee (on top of the LexiComp license fee).
  • Unique features are:
    • General LexiDrugs includes a table of drugs that shouldn’t be crushed.⭐
    • General LexiDrugs monographs include prices.⭐

 

A mnemonic asks the student to think of "x" "drugs" as a table of drugs that shouldn't be crushed, and to think of the "s" as a dollar sign.

(The mnemonic for not crushing drugs “x” “Drugs” is not as obvious as I’d like)

 

Martindale:  The Complete Drug Reference via LexiComp

  • UNMC pays LexiComp an extra fee to provide Martindale’s
  • Unique feature:  Martindale’s provides all the drug names you need to create a very thorough keyword search.⭐

 

A picture of. a mnemonic device. Think of the word "Complete" in the resource title as standing for "Complete" list of names needed for a comprehensive search.

 

AHFS DI

  • UNMC pays LexiComp an extra fee to provide the AHFS DI.
  • Do not confuse the AHFS DI with AHFS essentials.

A picture showing that the student should not use AFHS Essentials but the AHFS DI results that are subjacent in the search result list.

Advantages of AHFS DI -­‐-­‐

  1. Online version is thoroughly referenced.
  2. Extremely thorough monographs.
  3. Good source for odd little pieces of info (pearls)  like information obtained from conference presentations/abstracts and personal communications with the manufacturer — Unique feature.  ⭐

The mnemonic below is a bit contrived.  Think of the letters “A” “H” “F” “S”  “D” “I” as the initials on a pearl ID bracelet.

A picture of an "AHFS DI" pearl identity bracelet.

Anticipate Weekly Resource Reviews and Resource Knowledge Assessments

The tutorial and tutorial assignment you will complete today will help you begin to become familiar with these resources.

To help you memorize the resource distinctives, I’ve added a resource review to the beginning of every week’s materials.

You will have a quiz that covers the resource distinctives

The mid-term exam will also cover this material.

 

Objective 3. Be able to access DailyMed, Clinical Pharmacology, LexiComp, AHFS Drug Information, and Martindale’s

Almost all drug resources available at UNMC can be reached in the same way.

  • Start at any unmc.edu homepage.
  • Click on the “Library” link in the list of links at the bottom of the page.

A picture of the list of links that appears at the bottom of some unmc.edu webpages.

  • Click on the “Resources” menu.

A screenshot shows the position of the "Resources" menu and the "Drug Resources" link.

  • Click on “Drug Resources”
  • Click on the link to the resource of interest.

 

Tutorial and Assignment

The tutorial and tutorial assignment will  give you a chance to practice using the compendia discussed today and will cover the session’s last two objectives:

Objective 4. Be able to find PPIs using Daily Med (MA)

Objective 5. Be able to generate custom AE, drug interaction, and compatibility reports using CP, Lexi-­‐Comp

Instructions:

  1.  Complete the tutorial at https://pressbooks.nebraska.edu/modi/front-matter/introduction/
  2. The tutorial contains questions and will provide feedback on your answers.
  3. After considering the feedback, record your best answer to each of the questions in a document.
  4. When you’ve finished the tutorial, return to Canvas and enter the best answers to the questions in the Canvas assignment/quiz entitled: “Major Online Drug Information Resources Tutorial Assignment”

 

Questions, Problems, Text Errors?

Before you leave, …

  • Do you have any questions or do you feel that clarification of some aspect of the materials would be helpful?
  • Have you noticed any errors or problems with course materials that you’d like to report?
  • Do you have any other comments?

If so, you can submit questions, comments, corrections, and concerns anonymously — or with your e-mail (your choice) — through this online form .  Alternatively, you’re always welcome to contact Cindy Schmidt directly 402-650-5056, cmschmidt@unmc.edu, or by making an appointment to meet with Cindy via Zoom.

Answers to questions or requests for clarification that are submitted anonymously will be answered in Canvas on the “Discussions” page for this course.

License

Icon for the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License

Introduction to Drug Information Copyright © by Cynthia M. Schmidt is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License, except where otherwise noted.

Share This Book